Summary
The aim of this study was to calculate the direct costs of illness in patients with advanced osteoarthritis of the hip and knee. Costs were reported retrospectively by a self-administered questionnaire, covering the period of 12 months prior to joint replacement. Total direct costs amounted to €2747.–, medical costs were €1148.–, and non-medical costs were €1599.–. Late-stage osteoarthritis is expensive because of high costs mainly from personal care and household assistance caused by severe loss of function.
Zusammenfassung
Ziel der Studie war es, die direkten Kosten von fortgeschrittenen Cox- und Gonarthrosen zu erfassen. Die Studie erhob retrospektiv mittels Fragebogen die direkten Krankheitskosten innerhalb von 12 Monaten vor der Gelenksersatzoperation. Die direkten Gesamtkosten machten €2747,– aus, davon medizinische Kosten €1148,– und nichtmedizinische Kosten €1599,–. Die Studie zeigt die hohen Kosten für Hilfspersonen durch Funktionsstörungen der fortgeschrittenen Arthrose.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literatur
Friedrich M, Rustler T, Hahne J. Prävalenz von auf eigenen Angaben basierenden muskuloskelettalen Schmerzen der österreichischen Bevölkerung. Wien Klin Wochenschr, 118: 82–89, 2006
Hunt IM, Silman AJ, Benjamin S, et al. The prevalence and associated features of chronic widespread pain in the community. Rheumatology, 35: 1172–1174, 1999
Reginster J-Y. The prevalence and burden of arthritis. Rheumatology, 41(Suppl 1): 3–6, 2002
Callahan LF, Yelin EH. The social and economic consequences of rheumatic disease. In: Klippel JH (ed) Primer on the rheumatic diseases, 12th edn. Atlanta: Arthritis Foundation, pp 1–4, 2001
Lawrence RC, Felson DT, Helmick CG, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, Part II. Arthritis Rheum, 58: 26–35, 2008
Irlenbusch U, Enders E-M, Traut H. Epidemiologische Untersuchungen zur generalisierten Osteoarthrose an einer städtischen und ländlichen Polpulation. Akt Rheumatol, 24: 27–34, 1999
Andrianakos A, Trontzas P, Christoyannis F, et al. Prevalence of rheumatic diseases in Greece; a crosssectional population based epidemiological study. The ESORDIG Study. J Rheumatol, 30: 1589–1601, 2003
Siegmeth W. Epidemiologie der fortgeschrittenen Arthrose in Österreich. Eine Untersuchung in 3 Bundesländern. Ludwig Boltzmann Forschungsstelle für Epidemiologie Rheumatischer Erkrankungen, 1992
Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum, 41: 1343–1355, 1998
van Saase JL, van Romunde LK, Cats A, et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis, 48: 271–280, 1989
Altman RD. Various aspects of the epidemiology of osteoarthritis. Rev Rhum Ed Fr, 15: 89S–92S, 1994
Loza E, Lopez-Gomez JM, Abasolo L, et al. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum, 61: 158–165, 2009
Gupta S, Hawker GA, Laporte A, et al. The economic burden of disabling hip and knee osteoarthritis from the perspective of individuals living with this condition. Rheumatology (Oxford), 44: 1531–1537, 2005
Leardini G, Salaffi F, Caporali R, et al. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol, 22: 699–706, 2004
Xie F, Thumboo J, Fong KY, et al. A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore. Value Health, 11(Suppl 1): S84–S90, 2008
Xie F, Thumboo J, Fong K-J, et al. Direct and indirect costs of osteoarthritis in Singapore: A comparative study among multiethnic Asian patients with osteoarthritis. J Rheumatol, 34: 165–171, 2007
Wagner E, Lackerbauer E, Siegmeth W. Direkte und indirekte Kosten der chronischen Polyarthritis und sozio-emotionale Auswirkungen dieser Krankheit – eine Untersuchung in Österreich. Wien Med Wochenschr, 155: 217–226, 2005
Lanes SF, Lanza LL, Radensky PW, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting. Arthritis Rheum, 40: 1475–1481, 1997
Yelin E, Wanke LA. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum, 42: 1209–1218, 1999
Nunez M, Nunez E, Segur JM, et al. Health-related quality of life and costs in patients with osteoarthritis on waiting list for total knee replacement. Osteoarthritis Cartilage, 15: 258–265, 2007
Fielden JM, Cumming JM, Horne JG, et al. Waiting for hip arthroplasty: economic costs and health outcomes. J Arthroplasty, 20: 990–997, 2005
White AG, Birnbaum HG, Janagap C. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med, 50: 998–1005, 2008
Gabriel SE, Michaud K. Epidemiologic studies in incidence, prevalence, mortality and comorbidity of the rheumatic diseases. Arthritis Res Ther, 11: 229, 2009
Rabenda V, Manette C, Lemmens R, et al. Direct and indirect costs attributable to osteoarthritis in active subjects. J Rheumatol, 33: 1152–1158, 2006
Hawker GA, Badley EM, Croxford R, et al. A population-based nested case-control study of the costs of hip and knee replacement surgery. Med Care, 47(7): 732–741, 2009
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagner, E. Direkte Kosten der fortgeschrittenen Cox- und Gonarthrose in Österreich. Wien Med Wochenschr 161, 44–52 (2011). https://doi.org/10.1007/s10354-010-0858-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10354-010-0858-2